Anti-inflammatory medication ibuprofen could cut the risk of the development of Parkinson's disease, research has indicated.
A study, to be published in journal Neurology, demonstrated that adults who regularly take ibuprofen are around one-third less likely to develop Parkinson's disease.
Researchers studied the usage of ibuprofen and other NSAIDS in 98,892 female nurses and 37,305 male health professionals. They classed two or more doses of ibuprofen per week as regular use.
The study found that those who took the drug has a 38 per cent lower risk of developing Parkinson's disease compared to those who did not use it at all. However, a larger analysis showed a 27 per cent reduction in risk.
Meanwhile, research published in the Journal of Neuroscience revealed the discovery of a protein pathway that regulates the survival of dopamine-producing nerve cells thought to be key in Parkinson's disease.